STOCKSCREENR

NVS

NYSE

Novartis AG

$147.85+4.91(+3.44%)Mkt Cap: $282.11B

Key Stats

Market Cap

$282.11B

P/E Ratio

21.18

EPS

$6.98

Dividend Yield

3.26%

52-Week Range

$104.93 — $170.46

Volume

1.32M

Avg Volume

2.27M

Beta

0.52

Price Alerts for NVS

Get alerted when NVS hits your target price.

$

Free — enter your email to get started

Valuation

P/E (TTM)

21.18

Forward P/E

16.80

PEG Ratio

2.37

P/S (TTM)

4.93

P/B (TTM)

7.08

P/FCF

173.61

EV/EBITDA

56.69x

EV/Sales

—

Financial Health

ROE (TTM)

0.32%

ROA (TTM)

0.11%

ROIC

0.04%

Gross Margin

0.75%

Operating Margin

0.30%

Net Margin

0.18%

Debt/Equity

1.22

Current Ratio

0.85

Growth

EPS Growth (YoY)

-0.10%

Revenue Growth (YoY)

+0.03%

EPS Growth (3Y)

+0.43%

EPS Growth (5Y)

+0.52%

Sales Growth (3Y)

+0.08%

Sales Growth (5Y)

+0.02%

EPS Est (This Year)

$8.80

EPS Est (Next Year)

$9.68

Dividends

Dividend Yield

—

Annual Dividend

$3.99

Payout Ratio

0.04%

Frequency

—

Ex-Dividend Date

2025-03-12

Cash/Share

$3.67

Analyst Consensus

2.0

Buy

1 = Strong Buy, 5 = Strong Sell

Price Target Range

$112.00$126.00$143.00
LowMedianHigh

Consensus Target: $127.00(-14.1% upside)

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

1.93B

Float

1.82B

Free Float %

93.95%

Technicals

RSI (14)

77.73

SMA 20

$149.12

SMA 50

$141.23

SMA 200

$128.83

ATR (14)

2.83

Volatility (Week)

0.01%

Volatility (Month)

0.01%

Pattern

—

Performance

1 Day

+0.73%

1 Week

+5.57%

1 Month

+11.77%

3 Months

+25.21%

6 Months

+33.45%

1 Year

—

YTD

+14.19%

All-Time High

$159.37

About

Sector

Healthcare

Industry

Drug Manufacturers - General

Country

CH

Exchange

NYSE

IPO Date

1996-11-07

Employees

75883

CEO

Vasant Narasimhan

Index Membership

—

Website

https://www.novartis.com

Novartis AG (NVS) is a healthcare company in the drug manufacturers - general industry listed on the NYSE. With a market capitalization of $282.11B, a P/E ratio of 21.18, and a dividend yield of 3.26%, NVS is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare NVS against other stocks using dozens of fundamental and technical filters.

Similar Stocks

NVO

Novo Nordisk A/S

$42.22

+4.79%

$187.63B

AZN

AstraZeneca PLC

$187.37

+1.17%

$290.48B

MRK

Merck & Co., Inc.

$109.15

-1.62%

$269.59B

JNJ

Johnson & Johnson

$229.85

+1.10%

$553.30B

PFE

Pfizer Inc.

$26.70

+1.68%

$151.88B

ABBV

AbbVie Inc.

$211.33

+3.65%

$373.79B

Frequently Asked Questions

What is Novartis AG's P/E ratio?

Novartis AG (NVS) has a trailing twelve-month (TTM) P/E ratio of 21.18. This is near the market average range. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Novartis AG pay a dividend?

No, Novartis AG (NVS) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Novartis AG's market cap?

Novartis AG (NVS) has a market capitalization of $282.11 billion, classifying it as a mega-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.

What do analysts think about NVS?

Wall Street analysts have a consensus "Buy" rating on Novartis AG (NVS) with an average score of 2.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $127.00 implies 14.1% downside from the current price.

How has NVS performed this year?

Novartis AG (NVS) has returned +14.19% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.